Table 4.
Proposed experiments | Criteria | Cell type/method | Expected outcomes |
UC-MSC characterisation | MSC marker analysis | UC-MSCs/flow cytometry | Meet ISCT guideline |
Differentiation potential | UC-MSCs/In vitro differentiation using commercial kits. | Adipogenic, chondrogenic, and osteogenic differentiation | |
Karyotype | UC-MSCs/G-banding method | Normal post-expansion | |
Growth factor, cytokines secretion | UC-MSCs/ProcartaPlex Immunoassays | Detection of cytokines and growth factors involves in anti-inflammatory and tissue regeneration process. | |
Metabolic evaluation | Mitochondrial activities | UC-MSCs/agilent seahorse XF cell mito stress test | Measurement of mitochondrial activities of UC-MSCs pre-administration |
Glycolysis | UC-MSCs/agilent seahorse XF glycolysis stress test | Measurement of glycolysis process of UC-MSC pre-administration | |
Immunoregulatory assessment | Lymphocyte Proliferation Assay | UC-MSCs+peripheral mononuclear cells from healthy donors | UC-MSCs inhibit the proliferation rate of lymphocytes in the present of PHA. |
UC-MSCs+peripheral mononuclear cells from patients with COPD | UC-MSCs inhibit the proliferation rate of lymphocytes in the present of PHA in a similar manner to healthy donor counterpart | ||
Growth factors and cytokines analysis | UC-MSC secretion profiles under xeno-free and serum-free culture conditions | UC-MSCs/procartaPlex immunoassays | Detection of cytokines and growth factors involves in anti-inflammatory and tissue regeneration process. |
Cytokine profiles from patients with COPD plasma | Patients with COPD plasma/procartaPlex immunoassays | Evaluation of cytokines involves in inflammatory response obtain from patients with COPD plasma before and after UC-MSC administration. | |
Interaction between UC-MSCs and patients with COPD’ lymphocytes | Media obtained from co-culture of UC-MSCs and peripheral mononuclear cells from patients with COPD/ProcartaPlex Immunoassays | Detection of cytokines involves in the anti-inflammatory functions of UC-MSCs. |
COPD, chronic obstructive pulmonary disease; GOLD, Global Initiative for Chronic Obstructive Lung Disease; ISCT, International Society for Cellular Therapy.